ADRB2 rs1042720: What Your Genotype Means
The rs1042720 variant is a specific genetic change located within the ADRB2 gene, which provides instructions for making the beta-2 adrenergic receptor. Researchers have investigated this variant for its potential associations with uterine muscle function and outcomes related to pregnancy and labor.
What each genotype means
Typical receptor function
This genotype represents the G allele at the rs1042720 position, often referred to in literature as the Gly27 variant. Research into this variant's role in uterine contractility and preterm labor risk has yielded mixed results across different populations, and it is not considered a definitive diagnostic marker. Please discuss any concerns regarding pregnancy outcomes or medication responses with your obstetrician or healthcare provider.
This genotype is common globally, though its prevalence varies significantly by ancestral background.
Heterozygous receptor variant
You carry one copy of each allele for this variant, which influences the structure of the beta-2 adrenergic receptor. Studies have investigated whether this variation affects how the uterus responds to signals during pregnancy, but findings remain inconsistent and are not sufficient to predict individual clinical outcomes. Always consult with your clinician regarding any medical management or medication dosing.
This heterozygous genotype is frequently observed in most human populations.
Alternative receptor variant
This genotype corresponds to the C allele at the rs1042720 position, sometimes identified as the Glu27 variant. While some studies have explored associations between this variant and uterine contractility or responses to beta-agonist medications, the evidence is limited and conflicting. This result should not be used to guide clinical decisions; please speak with your pharmacist or doctor regarding any prescribed treatments.
This genotype is found at varying frequencies worldwide, appearing in a significant portion of the general population.
Understanding the rs1042720 Variant
The rs1042720 variant is a single nucleotide polymorphism (SNP) found within the ADRB2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in the coding region of the gene, meaning it has the potential to alter the structure or function of the protein it encodes. Scientists track these variations to understand how subtle differences in our genetic code might influence biological processes, such as how cells respond to chemical signals in the body. Because this variant is common, it has been the subject of numerous studies aiming to determine if it contributes to observable differences in human health, particularly in the context of reproductive physiology and smooth muscle regulation.
The Role of the ADRB2 Gene
The ADRB2 gene encodes the beta-2 adrenergic receptor, a protein that sits on the surface of various cell types, including those in the smooth muscle of the uterus. This receptor acts as a docking site for signaling molecules like adrenaline. When activated, the receptor typically triggers a cascade of events that leads to the relaxation of smooth muscle tissue. In the context of pregnancy, the proper function of these receptors is thought to be important for maintaining uterine quiescence, or the state of relaxation, until the appropriate time for labor. Because of this role, researchers have hypothesized that variations in the ADRB2 gene might influence how effectively the uterus responds to signals that either promote or inhibit contractions, potentially impacting the timing and progression of labor.
Research and Evidence Strength
The association between ADRB2 variants and reproductive outcomes is a complex area of study. While some research has explored whether specific genotypes correlate with the risk of preterm labor or the effectiveness of medications used to delay labor, the evidence remains mixed. Studies often report conflicting results, which may be due to differences in study design, the specific populations being analyzed, or the influence of other genetic and environmental factors. Currently, the evidence linking rs1042720 to specific clinical outcomes is considered moderate. It is important to note that genetic associations observed in research studies do not necessarily translate to individual clinical predictions. The biological mechanisms involved in pregnancy are multifactorial, and a single genetic variant is rarely the sole determinant of a complex health outcome.
Interpreting Your Genetic Information
If you have information about your rs1042720 genotype, it is essential to view it within the context of current scientific understanding. Genetic research provides insights into population-level trends rather than individual medical diagnoses. Because the link between this variant and reproductive health is not definitive, this information should not be used to predict personal health outcomes or make medical decisions. If you are concerned about pregnancy, labor, or the use of specific medications, you should discuss these topics with your obstetrician or a qualified healthcare provider. They can provide guidance based on your complete medical history and current clinical standards. Never change or stop any prescribed treatment based on genetic data without first consulting with your clinician or pharmacist.
How common is this variant?
The rs1042720 variant is common, with a global minor allele frequency of approximately 0.45, meaning the different genotypes are widely distributed across various ancestral populations.
Frequently asked questions
Is rs1042720 a diagnostic test for preterm labor?
No, rs1042720 is not a diagnostic test. While researchers study this variant for its potential associations with uterine function, it cannot predict whether an individual will experience preterm labor.
Can I use this genotype to choose a medication?
No. You should never use genetic information to select or adjust medications. Always consult your clinician or pharmacist regarding any treatment plans or medication dosing.
Why do studies show different results for this variant?
Genetic studies often show mixed results due to differences in population ancestry, sample sizes, and environmental factors. Complex traits like labor are influenced by many genes and external variables, not just one SNP.
Where can I find more information about ADRB2?
You can find reliable information about the ADRB2 gene and its functions through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI).
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1042720?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADRB2
Variant in the beta-2 adrenergic receptor linked to metabolic regulation, exercise-induced lipolysis, and endurance performance.
Synonymous polymorphism in the beta-2 adrenergic receptor (Gln27Glu) modulating receptor down-regulation.
The Gln27Glu variant in the beta-2 adrenergic receptor is associated with metabolic and vascular responses to exercise.
Modulates beta-2 adrenergic receptor expression and cardiovascular reactivity.
This variant in the beta-2 adrenergic receptor gene is associated with differential responses to beta-agonist therapy in asthma patients.
Functional variant in the beta-2 adrenergic receptor linked to metabolic rate and cardiovascular reactivity.